Carl W. Ehmann
Director/Board Member bij MUSC Foundation for Research Development
Profiel
Carl W.
Ehmann is currently the Director at MUSC Foundation for Research Development and the Treasurer & Director at Guadalupe Center, Inc. Previously, he worked as a Director at Barrier Therapeutics, Inc. from 2004 to 2008, Director-Clinical Research & Dermatology at Hoffman-LaRoche F & Co. AG, VP-Pharmaceutical Research & Development at Bristol Myers Squibb Co., and Executive VP, Head-Global Research & Development at Johnson & Johnson.
He received his undergraduate and doctorate degrees from State University of New York at Buffalo.
Actieve functies van Carl W. Ehmann
| Bedrijven | Functie | Begin |
|---|---|---|
| MUSC Foundation for Research Development | Director/Board Member | - |
Guadalupe Center, Inc.
 Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Director/Board Member | - |
Eerdere bekende functies van Carl W. Ehmann
| Bedrijven | Functie | Einde |
|---|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Director/Board Member | 04-08-2008 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Carl W. Ehmann
| State University of New York at Buffalo | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
Hoffman-LaRoche F & Co. AG
Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
| MUSC Foundation for Research Development | |
Guadalupe Center, Inc.
Guadalupe Center, Inc. Services to the Health IndustryHealth Services Guadalupe Center, Inc. provides educational, social, and other support programs and resources for the children and families of Immokalee. The company was founded in 1982 and is headquartered in Immokalee, FL. | Health Services |
